Phase II/III study of Fosbretabulin in patients with Glioblastoma multiforme

Trial Profile

Phase II/III study of Fosbretabulin in patients with Glioblastoma multiforme

Planning
Phase of Trial: Phase II/III

Latest Information Update: 03 Feb 2016

At a glance

  • Drugs Fosbretabulin (Primary)
  • Indications Glioblastoma
  • Focus Therapeutic Use
  • Most Recent Events

    • 03 Feb 2016 According to an Oxigene media release, the company will not initiate this study in 2016 because most of their current efforts for developing CA4P will be on FOCUS (see CT profile 700257531).
    • 01 Oct 2015 New trial record
    • 29 Sep 2015 According to Oxigene media release, company is planning to initiate this trial in the second half of 2016.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top